| Antigen | An 8 amino acid peptide sequence (gene accession # BAB87245.1) (designated p73B13-P, control peptide) mapping at the C-terminus of human p73¿ (1) was used to generate anti-human p73¿. The peptide was coupled with KLH (carrier protein) |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | The 8 AA human P73B13-P immunogenic peptide sequence has no significant homology with p73¿. It is conserved in monkey p73. Antibody crossreactivity in various species is not established |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |